Suppr超能文献

应用成骨蛋白-1(骨形态发生蛋白-7)治疗先天性胫骨假关节:1例报告

Treatment of a congenital pseudarthrosis of the tibia by osteogenic protein-1 (bone morphogenetic protein-7): a case report.

作者信息

Anticevic Darko, Jelic Mislav, Vukicevic Slobodan

机构信息

Department of Orthopaedic Surgery, School of Medicine, University of Zagreb, Zagreb, Croatia.

出版信息

J Pediatr Orthop B. 2006 May;15(3):220-1. doi: 10.1097/01.bpb.0000194439.75378.ac.

Abstract

Congenital pseudarthrosis of the tibia remains one of the most difficult orthopaedic problems to treat. Before the use of a recombinant bone morphogenetic protein (bone morphogenetic protein-7; osteogenic protein-1) the patient with congenital pseudarthrosis of the tibia in this report had had 12 unsuccessful surgeries. Five months after radical resection of sclerotic tibial segments, Ilizarov fixation and administration of osteogenic protein-1 osteogenic device, the congenital pseudarthrosis of the tibia healed; at 45 months the tibia increased in size and the patient was fully weight bearing.

摘要

先天性胫骨假关节仍然是最难治疗的骨科问题之一。在使用重组骨形态发生蛋白(骨形态发生蛋白-7;成骨蛋白-1)之前,本报告中的先天性胫骨假关节患者已经历了12次手术均未成功。在对硬化的胫骨节段进行根治性切除、应用伊里扎洛夫固定架并给予成骨蛋白-1成骨装置五个月后,先天性胫骨假关节愈合;在45个月时,胫骨增粗,患者可完全负重。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验